Moodley, R.; Mashaba, C.; Rakodi, G.H.; Ncube, N.B.; Maphoru, M.V.; Balogun, M.O.; Jordan, A.; Warner, D.F.; Khan, R.; Tukulula, M.
New Quinoline–Urea–Benzothiazole Hybrids as Promising Antitubercular Agents: Synthesis, In Vitro Antitubercular Activity, Cytotoxicity Studies, and In Silico ADME Profiling. Pharmaceuticals 2022, 15, 576.
https://doi.org/10.3390/ph15050576
AMA Style
Moodley R, Mashaba C, Rakodi GH, Ncube NB, Maphoru MV, Balogun MO, Jordan A, Warner DF, Khan R, Tukulula M.
New Quinoline–Urea–Benzothiazole Hybrids as Promising Antitubercular Agents: Synthesis, In Vitro Antitubercular Activity, Cytotoxicity Studies, and In Silico ADME Profiling. Pharmaceuticals. 2022; 15(5):576.
https://doi.org/10.3390/ph15050576
Chicago/Turabian Style
Moodley, Rashmika, Chakes Mashaba, Goitsemodimo H. Rakodi, Nomagugu B. Ncube, Mabuatsela V. Maphoru, Mohammed O. Balogun, Audrey Jordan, Digby F. Warner, Rene Khan, and Matshawandile Tukulula.
2022. "New Quinoline–Urea–Benzothiazole Hybrids as Promising Antitubercular Agents: Synthesis, In Vitro Antitubercular Activity, Cytotoxicity Studies, and In Silico ADME Profiling" Pharmaceuticals 15, no. 5: 576.
https://doi.org/10.3390/ph15050576
APA Style
Moodley, R., Mashaba, C., Rakodi, G. H., Ncube, N. B., Maphoru, M. V., Balogun, M. O., Jordan, A., Warner, D. F., Khan, R., & Tukulula, M.
(2022). New Quinoline–Urea–Benzothiazole Hybrids as Promising Antitubercular Agents: Synthesis, In Vitro Antitubercular Activity, Cytotoxicity Studies, and In Silico ADME Profiling. Pharmaceuticals, 15(5), 576.
https://doi.org/10.3390/ph15050576